Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-06-25

FDA Approved: METHYLPHENIDATE TRANSDERMAL SYSTEM — Supplemental Application (PADAGIS US LLC)

View source ↗

Summary

FDA approved a supplemental application for the Methylphenidate Transdermal System (methylphenidate patch) by PADAGIS US LLC. The product is approved for the tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Methylphenidate Transdermal System (methylphenidate)

Snippet

SUPPL AP for METHYLPHENIDATE TRANSDERMAL SYSTEM (METHYLPHENIDATE)